HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
10.11 USD
+0.03 (+0.3%)
10.11 USD
0 (0%)
Overall HLN gets a fundamental rating of 6 out of 10. We evaluated HLN against 191 industry peers in the Pharmaceuticals industry. HLN scores excellent on profitability, but there are some minor concerns on its financial health. HLN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
HLN had positive earnings in the past year.
HLN had a positive operating cash flow in the past year.
In the past 5 years HLN has always been profitable.
In the past 5 years HLN always reported a positive cash flow from operatings.
1.2 Ratios
HLN has a better Return On Assets (4.20%) than 85.34% of its industry peers.
HLN has a Return On Equity of 8.92%. This is amongst the best in the industry. HLN outperforms 84.29% of its industry peers.
HLN has a better Return On Invested Capital (6.11%) than 83.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
With an excellent Profit Margin value of 12.84%, HLN belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.
HLN's Profit Margin has improved in the last couple of years.
The Operating Margin of HLN (21.31%) is better than 89.01% of its industry peers.
HLN's Operating Margin has improved in the last couple of years.
HLN has a better Gross Margin (60.75%) than 70.68% of its industry peers.
HLN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HLN is destroying value.
Compared to 1 year ago, HLN has less shares outstanding
Compared to 5 years ago, HLN has less shares outstanding
The debt/assets ratio for HLN is higher compared to a year ago.
2.2 Solvency
HLN has an Altman-Z score of 2.32. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLN has a Altman-Z score of 2.32. This is in the better half of the industry: HLN outperforms 61.78% of its industry peers.
HLN has a debt to FCF ratio of 5.11. This is a neutral value as HLN would need 5.11 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.11, HLN belongs to the top of the industry, outperforming 82.20% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that HLN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.53, HLN is not doing good in the industry: 64.92% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.75
WACC8.2%
2.3 Liquidity
HLN has a Current Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.98, HLN is doing worse than 85.34% of the companies in the same industry.
HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLN has a Quick ratio of 0.78. This is amonst the worse of the industry: HLN underperforms 84.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
HLN shows a decrease in Revenue. In the last year, the revenue decreased by -0.61%.
Measured over the past years, HLN shows a small growth in Revenue. The Revenue has been growing by 5.78% on average per year.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
Based on estimates for the next years, HLN will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.10% on average per year.
Based on estimates for the next years, HLN will show a small growth in Revenue. The Revenue will grow by 3.76% on average per year.
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 20.22, the valuation of HLN can be described as rather expensive.
HLN's Price/Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 80.10% of the companies in the same industry.
HLN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 17.44 indicates a rather expensive valuation of HLN.
HLN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HLN is cheaper than 79.58% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. HLN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.22 | ||
| Fwd PE | 17.44 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 81.68% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 84.82% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.86 | ||
| EV/EBITDA | 15.2 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.52
PEG (5Y)1.15
EPS Next 2Y8.04%
EPS Next 3Y8.69%
5. Dividend
5.1 Amount
HLN has a Yearly Dividend Yield of 1.83%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.61, HLN pays a better dividend. On top of this HLN pays more dividend than 92.67% of the companies listed in the same industry.
HLN's Dividend Yield is comparable with the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
5.2 History
HLN has paid a dividend for at least 10 years, which is a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
39.53% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
10.11
+0.03 (+0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap45.02B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price Target11.45 (13.25%)
Short Float %0.32%
Short Ratio1.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.24%
PT rev (3m)-3.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0.31%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.22 | ||
| Fwd PE | 17.44 | ||
| P/S | 2.98 | ||
| P/FCF | 16.86 | ||
| P/OCF | 14.53 | ||
| P/B | 2.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.2 |
EPS(TTM)0.5
EY4.95%
EPS(NY)0.58
Fwd EY5.74%
FCF(TTM)0.6
FCFY5.93%
OCF(TTM)0.7
OCFY6.88%
SpS3.4
BVpS4.89
TBVpS-3.04
PEG (NY)3.52
PEG (5Y)1.15
Graham Number7.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.32 |
F-Score6
WACC8.2%
ROIC/WACC0.75
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.42%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 6 / 10 to HLN.
Can you provide the valuation status for HALEON PLC-ADR?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for HLN stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.22 and the Price/Book (PB) ratio is 2.07.
Can you provide the dividend sustainability for HLN stock?
The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 39.53%.